密歇根放射肿瘤学质量联盟:一项改善放射肿瘤学照护质量的新举措
本文描述一项十年前发起的自愿性全州放射肿瘤学质量改进协作,采用观察性数据集评估28家参与机构逾2万例患者年度质量指标的实施前后依从性变化。乳腺癌指南一致性大分割放疗使用率从47%升至97%,靶区覆盖与心脏剂量限值依从率从46%升至86%,肺癌运动评估从52%升至94%,肺癌标准命名从53%升至82%、乳腺癌从80%升至94%(均P<.001)。
要点
- 乳腺癌指南一致性大分割放疗使用率从47%升至97%(P<.001)。
- 靶区覆盖与心脏剂量限值依从率从46%升至86%(P<.001)。
- 肺癌运动评估从52%升至94%,标准命名肺癌从53%升至82%、乳腺癌从80%升至94%(均P<.001)。
核心结论
- 观察性分析不能完全排除时代趋势,但美国其他地区最佳实践采纳缓慢的背景数据及参与者定性反馈提示,该举措改善了成员机构的放射肿瘤学照护一致性、效率和质量,可能成为肿瘤学质量改进的通用模式。
研究设计与样本
- 观察性数据集,评估年度质量改进指标实施前后的依从性,数据来自28家参与放射肿瘤学实践机构逾2万例患者。
- 每年三次会议,专家就领域趋势发言并激发关于质量改进潜在目标的讨论,提供各站点实践的去标识化数据。
- 遵循质量改进报告卓越标准(Standards for Quality Improvement Reporting Excellence)指南描述方法与措施。
- 采用混合效应回归模型(站点水平随机效应)比较基线时与当前活跃措施的依从性。
主要发现
- 乳腺癌指南一致性大分割放疗使用率从47%升至97%(P<.001)。
- 靶区覆盖目标与心脏剂量限值依从率从46%升至86%(P<.001)。
- 肺癌患者运动评估从52%升至94%(P<.001)。
- 标准命名使用率肺癌患者从53%升至82%、乳腺癌患者从80%升至94%(均P<.001)。
- 依从性提升还包括靶区或正常组织剂量、运动管理以及勾画结构命名的一致性(质量评估的前提条件)。
关键数值与推荐
- 乳腺癌指南一致性大分割放疗使用率从47%升至97%(P<.001)。
- 靶区覆盖目标与心脏剂量限值依从率从46%升至86%(P<.001)。
- 肺癌患者运动评估从52%升至94%(P<.001)。
- 标准命名使用率肺癌患者从53%升至82%、乳腺癌患者从80%升至94%(均P<.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 观察性分析不能完全排除时代趋势。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Numerous quality measures have been proposed in radiation oncology, and initiatives to improve access to high-complexity care, quality, and equity are needed. We describe the design and evaluate effect of a voluntary statewide collaboration for quality improvement in radiation oncology initiated a decade ago. METHODS AND MATERIALS: We evaluate compliance before and since implementation of annual metrics for quality improvement, using an observational data set with information from more than 20,000 patients treated in the 28 participating radiation oncology practices. At thrice-yearly meetings, experts have spoken regarding trends within the field and inspired discussions regarding potential targets for quality improvement. Blinded data on practices at various sites have been provided. Following Standards for Quality Improvement Reporting Excellence guidelines, we describe the approach and measures the program has implemented. To evaluate effect, we compare compliance at baseline and now with active measures using mixed effects regression models with site-level random effects. RESULTS: Compliance has increased, including use of guideline-concordant hypofractionated radiation therapy, doses to targets or normal tissues, motion management, and consistency in delineating and naming contoured structures (a precondition for quality evaluation). For example, use of guideline-concordant hypofractionation for breast cancer increased from 47% to 97%, adherence to target coverage goals and heart dose limits for dose increased from 46% to 86%, motion assessment in patients with lung cancer increased from 52% to 94%, and use of standard nomenclature increased from 53% to 82% for lung patients and from 80% to 94% for breast patients (all P < .001). CONCLUSIONS: Although observational analysis cannot fully exclude secular trends, contextual data revealing slow uptake of best practices elsewhere in the United States and qualitative feedback from participants suggests that this initiative has improved the consistency, efficiency, and quality of radiation oncology care in its member practices and may be a model for oncology quality improvement more generally.
引用
- Jagsi R, Schipper M, Mietzel M, et al. The Michigan Radiation Oncology Quality Consortium: A Novel Initiative to Improve the Quality of Radiation Oncology Care. Int J Radiat Oncol Biol Phys. 2022. PMID: 35124133. doi:10.1016/j.ijrobp.2022.01.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。